17beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats (Q28577156)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 18, 2010

Language	Label	Description	Also known as
English	17beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats	scientific article published on December 18, 2010

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats (English)

1 reference

PubMed publication ID

31 January 2017

17beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats (English)

1 reference

10.1007/S11033-010-0630-0

https://api.crossref.org/works/10.1007/S11033-010-0630-0

20 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21170593

20 November 2024

author name string

Yu-Hong Cui

1

1 reference

PubMed publication ID

31 January 2017

Zhi Tan

2

1 reference

PubMed publication ID

31 January 2017

Xiao-Dong Fu

3

1 reference

PubMed publication ID

31 January 2017

Qiu-Ling Xiang

4

1 reference

PubMed publication ID

31 January 2017

Jin-Wen Xu

5

1 reference

PubMed publication ID

31 January 2017

Ting-Huai Wang

6

1 reference

PubMed publication ID

31 January 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21170593

20 November 2024

publication date

1 November 2011

1 reference

PubMed publication ID

31 January 2017

18 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21170593

20 November 2024

full work available at URL

http://link.springer.com/content/pdf/10.1007/s11033-010-0630-0.pdf

1 reference

10.1007/S11033-010-0630-0

https://api.crossref.org/works/10.1007/S11033-010-0630-0

20 November 2024

http://link.springer.com/article/10.1007/s11033-010-0630-0/fulltext.html

1 reference

10.1007/S11033-010-0630-0

https://api.crossref.org/works/10.1007/S11033-010-0630-0

20 November 2024

http://link.springer.com/content/pdf/10.1007/s11033-010-0630-0

1 reference

10.1007/S11033-010-0630-0

https://api.crossref.org/works/10.1007/S11033-010-0630-0

20 November 2024

Molecular Biology Reports

1 reference

PubMed publication ID

31 January 2017

38

1 reference

PubMed publication ID

31 January 2017

8

1 reference

PubMed publication ID

31 January 2017

4885–4892

1 reference

PubMed publication ID

31 January 2017

Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Incidence and epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Estrogen receptor beta protects the murine heart against left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Caveolae structure and function

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Site specific differential activation of ras/raf/ERK signaling in rabbit isoproterenol-induced left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Reduction of caveolin-3 expression does not inhibit stretch-induced phosphorylation of ERK2 in skeletal muscle myotubes

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

17beta-estradiol attenuates the development of pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Organization and regulation of mitogen-activated protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Regulation of cardiac hypertrophy by intracellular signalling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Modulation of Myoblast Fusion by Caveolin-3 in Dystrophic Skeletal Muscle Cells: Implications for Duchenne Muscular Dystrophy and Limb-Girdle Muscular Dystrophy-1C

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Caveolins, liquid-ordered domains, and signal transduction

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Angiotensin-converting enzyme inhibitor suppresses activation of calcineurin in renovascular hypertensive rats

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Effects of caveolin-1 on the 17β-estradiol-mediated inhibition of VSMC proliferation induced by vascular injury

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0630-0

21 January 2018

Effect of hormone replacement therapy on left ventricular hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc- fa cp rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible involvement of caveolin-1 in the inhibition of endothelin-1 induced proliferation of vascular smooth muscle cells by 17beta-estradiol

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender differences in blood pressure and heart rate in spontaneously hypertensive and Wistar-Kyoto rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteomic expression analysis of cardiomyocytes subjected to proteasome inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myot

1 reference

https://pubmed.ncbi.nlm.nih.gov/21170593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11033-010-0630-0

1 reference

PubMed publication ID

31 January 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

PubMed publication ID

31 January 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28577156&oldid=2277468360"